| Rare mutations in XRCC2 increase the risk of breast cancer DJ Park, F Lesueur, T Nguyen-Dumont, M Pertesi, F Odefrey, F Hammet, ... The American Journal of Human Genetics 90 (4), 734-739, 2012 | 226 | 2012 |
| Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer SV Tavtigian, PJ Oefner, D Babikyan, A Hartmann, S Healey, ... The American Journal of Human Genetics 85 (4), 427-446, 2009 | 217 | 2009 |
| Determining the effectiveness of High Resolution Melting analysis for SNP genotyping and mutation scanning at the TP53 locus S Garritano, F Gemignani, C Voegele, T Nguyen-Dumont, ... BMC genetics 10, 1-12, 2009 | 189 | 2009 |
| Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids N Alcala, N Leblay, AAG Gabriel, L Mangiante, D Hervás, T Giffon, ... Nature communications 10 (1), 3407, 2019 | 163 | 2019 |
| Rare key functional domain missense substitutions in MRE11A, RAD50, and NBNcontribute to breast cancer susceptibility: results from a Breast Cancer Family … F Damiola, M Pertesi, J Oliver, F Le Calvez-Kelm, C Voegele, EL Young, ... Breast Cancer Research 16, 1-16, 2014 | 143 | 2014 |
| No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing DF Easton, F Lesueur, B Decker, K Michailidou, J Li, J Allen, C Luccarini, ... Journal of medical genetics 53 (5), 298-309, 2016 | 142 | 2016 |
| Beta HPV38 oncoproteins act with a hit-and-run mechanism in ultraviolet radiation-induced skin carcinogenesis in mice D Viarisio, K Müller-Decker, R Accardi, A Robitaille, M Dürst, K Beer, ... PLoS pathogens 14 (1), e1006783, 2018 | 121 | 2018 |
| Identification of novel long non-coding RNAs deregulated in hepatocellular carcinoma using RNA-sequencing D Degli Esposti, H Hernandez-Vargas, C Voegele, N Fernandez-Jimenez, ... Oncotarget 7 (22), 31862, 2016 | 97 | 2016 |
| Rare, evolutionarily unlikely missense substitutions in CHEK2contribute to breast cancer susceptibility: results from a breast cancer family registry case-control … F Le Calvez-Kelm, F Lesueur, F Damiola, M Vallée, C Voegele, ... Breast Cancer Research 13, 1-12, 2011 | 95 | 2011 |
| Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study MI Hosen, M Sheikh, M Zvereva, G Scelo, N Forey, G Durand, C Voegele, ... EBioMedicine 53, 2020 | 66 | 2020 |
| Rare Mutations in RINT1 Predispose Carriers to Breast and Lynch Syndrome–Spectrum Cancers DJ Park, K Tao, F Le Calvez-Kelm, T Nguyen-Dumont, N Robinot, ... Cancer discovery 4 (7), 804-815, 2014 | 62 | 2014 |
| Urinary TERT promoter mutations as non-invasive biomarkers for the comprehensive detection of urothelial cancer PH Avogbe, A Manel, E Vian, G Durand, N Forey, C Voegele, M Zvereva, ... EBioMedicine 44, 431-438, 2019 | 59 | 2019 |
| Elucidating Genomic Characteristics of Lung Cancer Progression from In Situ to Invasive Adenocarcinoma C Vinayanuwattikun, F Le Calvez-Kelm, B Abedi-Ardekani, D Zaridze, ... Scientific reports 6 (1), 31628, 2016 | 50 | 2016 |
| RAD51 and Breast Cancer Susceptibility: No Evidence for Rare Variant Association in the Breast Cancer Family Registry Study F Le Calvez-Kelm, J Oliver, F Damiola, N Forey, N Robinot, G Durand, ... PLoS One 7 (12), e52374, 2012 | 46 | 2012 |
| Multigene testing of moderate-risk genes: be mindful of the missense EL Young, BJ Feng, AW Stark, F Damiola, G Durand, N Forey, TC Francy, ... Journal of Medical Genetics 53 (6), 366-376, 2016 | 45 | 2016 |
| A Laboratory Information Management System (LIMS) for a high throughput genetic platform aimed at candidate gene mutation screening C Voegele, SV Tavtigian, D De Silva, S Cuber, A Thomas, ... Bioinformatics 23 (18), 2504-2506, 2007 | 44 | 2007 |
| Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity L Mangiante, N Alcala, A Sexton-Oates, A Di Genova, A Gonzalez-Perez, ... Nature Genetics 55 (4), 607-618, 2023 | 38 | 2023 |
| Development of Sensitive Droplet Digital PCR Assays for Detecting Urinary TERT Promoter Mutations as Non-Invasive Biomarkers for Detection of Urothelial Cancer MI Hosen, N Forey, G Durand, C Voegele, S Bilici, PH Avogbe, ... Cancers 12 (12), 3541, 2020 | 32 | 2020 |
| Low-coverage exome sequencing screen in formalin-fixed paraffin-embedded tumors reveals evidence of exposure to carcinogenic aristolochic acid X Castells, S Karanović, M Ardin, K Tomić, E Xylinas, G Durand, S Villar, ... Cancer Epidemiology, Biomarkers & Prevention 24 (12), 1873-1881, 2015 | 31 | 2015 |
| A universal open-source electronic laboratory notebook C Voegele, B Bouchereau, N Robinot, J McKay, P Damiecki, L Alteyrac Bioinformatics 29 (13), 1710-1712, 2013 | 30 | 2013 |
Florence Le Calvez-KelmScientist, International Agency for Research on Cancer在 iarc.fr 的电子邮件经过验证
